SALAM seeks to address inequalities in access to innovation, as a JRC report highlights AI’s potential for earlier cardiovascular detection while warning of unequal benefits across health systems.
SALAM project contributes to one of the most important challenges emerging in cardiovascular care today: making innovation useful where access to specialised services is still fragile, delayed or uneven. By combining Hospital Hubs in Beirut and Irbid, telecardiology platforms, Medical Mobile Units and targeted training for healthcare professionals, technicians and caregivers, the project works to shorten the distance between communities and cardiac care in Lebanon and Jordan.
This is why the current debate on Artificial Intelligence (A) in cardiovascular care matters for SALAM. The key question is no longer only whether new digital tools are becoming more advanced. It is whether they can help care reach people earlier, support professionals more effectively and strengthen health systems in places where specialist services are harder to access.
A recent report from the European Commission’s Joint Research Centre (JRC), “Artificial Intelligence in Cardiovascular Care: Navigating the Gap Between Technical Progress and Clinical Impact”, shows that artificial intelligence is already moving into important parts of cardiovascular care. The report points to growing applications across prevention, diagnosis, treatment support and health system optimisation, with some tools now mature enough to move closer to routine practice.
This matters in a field where the need remains urgent. Cardiovascular disease still claims more than 1.7 million lives every year in Europe, and one in five of those deaths is considered preventable. Against this background, the report does not present artificial intelligence as a trend to admire from a distance. It raises a more practical question: can these tools produce real benefits for patients and health systems safely, equitably and at scale?
The report is clear that the promise is real. Artificial intelligence can support earlier risk detection, faster diagnosis, better-informed treatment decisions and more efficient clinical workflows. Among the applications with the strongest practical promise, it highlights tools that can help clinicians analyse heart scans faster (AI-assisted echocardiography), read ECGs with greater consistency (automated ECG interpretation), understand whether a blocked artery is really compromising blood flow (CT-derived fractional flow reserve), and speed up decisions when every minute counts after a stroke (AI-supported stroke triage).
In practical terms, this can mean faster assessment, more consistent interpretation and less time lost before treatment begins. For patients, that may translate into earlier diagnosis and more targeted care. For professionals and health services, it may help improve decision-making and reduce delays in critical moments.
But the report is equally clear on a part that usually gets buried under the hype: the limits of the current conversation. Technical performance is not the same as clinical impact.
Many tools perform well in controlled settings, but much less is known about what happens when they enter ordinary care pathways, real hospital workflows and uneven healthcare systems. A model can look impressive on paper and still fail where it matters most: improving outcomes, supporting professionals, fitting daily practice and reducing pressure on overstretched services. Innovation only becomes meaningful when it fits the daily reality of care.
This is exactly the perspective that makes the report especially relevant for SALAM. In fragile and underserved contexts, the question is not simply whether a digital tool works in principle. The question is whether the surrounding system is able to make that tool useful in practice.
Where specialist care is shaped by distance, uneven infrastructure and limited capacity, innovation cannot remain confined to well-resourced environments. If advanced tools remain concentrated only in the well-resourced academic centres or in the strongest hospitals and best-equipped systems, AI may widen disparities instead of narrowing them. The report says this explicitly: smaller hospitals and less affluent systems often lack the infrastructure, workforce capacity and financing mechanisms needed to implement and sustain these innovations.
The issue is not only technological progress. It is access.
This is where SALAM’s contribution becomes especially clear. The project does not approach digital health as an isolated layer added on top of existing services. It addresses the wider conditions that make specialised care more reachable: connected service points, telecardiology support, territorial outreach, mobile healthcare delivery and the training needed to make these systems work.
One of the report’s most interesting examples makes that connection even clearer. Among the AI applications with the strongest practical promise, the report highlights AI-assisted echocardiography. The reason is simple: AI can help non-specialist operators acquire diagnostic-quality cardiac images with minimal training, making assessment more available in places where specialist expertise is scarce. Translated from technical language, this means something very concrete: cardiac assessment can happen earlier, referrals can happen faster, and there may be more chances to intervene before a cardiovascular event becomes more severe.
This logic speaks directly to SALAM. In contexts where specialist care is unevenly distributed, the question is not only the tool itself or whether it works in ideal conditions. It’s whether the surrounding chain exists to support it. That includes trained staff, referral pathways, territorial outreach, mobile services and a system capable of connecting local need with specialist support. SALAM’s architecture reflects this exact approach. The Hospital Hubs, telecardiology platform, the cross-border training and Medical Mobile Units are not separate components. They are part of the same attempt to shorten the distance between communities and cardiac care — and, in doing so, to change who gets seen, when, and by whom.
The report is also underlines another critical point: workforce readiness is not secondary. Even strongest digital tools may fail when systems lack the skills, implementation capacity or the organisational support needed to integrate them into practice. Technology does not improve care by itself.
This, again, is where SALAM’s added value is immediate. Training is not an accessory element of the project. It is one of the conditions that makes innovation usable at all. By investing in healthcare professionals, technicians and caregivers, SALAM reflects the same reality the JRC keeps underlining: technology does not scale on its own. People scale it, or it stalls.
In this sense, the broader lesson of the JRC report aligns closely with SALAM’s own logic. The future of cardiovascular AI will not be decided only in highly specialised centres or ideal implementation settings. It will also be decided where implementation is hardest: where infrastructure is patchy, resources are tight and specialist care arrives late.
That is why the real story is not the algorithm alone. It is whether better cardiovascular care can become more reachable, more connected and more equitable for the communities that are too often reached last. And this is precisely where SALAM places its contribution.
Last Update
14/04/2026
Next Med